ENTRY       D11048                      Drug
NAME        Upadacitinib hydrate (JAN);
            Upadacitinib hemihydrate;
            Rinvoq (TN)
FORMULA     (C17H19F3N6O)2. H2O
EXACT_MASS  778.3251
MOL_WEIGHT  778.7504
CLASS       Anti-inflammatory
             DG01985  Disease modifying anti-rheumatic drug (DMARD)
              DG02020  JAK inhibitor
            Dermatological agent
             DG03243  Atopic dermatitis agent
            Metabolizing enzyme substrate
             DG01644  CYP2D6 substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
REMARK      Therapeutic category: 3999
            ATC code: L04AA44
            Chemical structure group: DG02829
            Product (DG02829): D10994<US> D11048<JP>
EFFICACY    Antirheumatic, Janus kinase (JAK) inhibitor
  DISEASE   Rheumatoid arthritis [DS:H00630]
            Psoriatic arthritis [DS:H01507]
            Atopic dermatitis [DS:H01358]
            Ulcerative colitis [DS:H01466]
            Ankylosing spondylitis [DS:H01674]
TARGET      JAK1 [HSA:3716] [KO:K11217]
  PATHWAY   hsa04630(3716)  JAK-STAT signaling pathway
METABOLISM  Enzyme: CYP3A4 [HSA:1576]; CYP2D6 [HSA:1565]
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L04 IMMUNOSUPPRESSANTS
               L04A IMMUNOSUPPRESSANTS
                L04AA Selective immunosuppressants
                 L04AA44 Upadacitinib
                  D11048  Upadacitinib hydrate (JAN) &lt;JP&gt;
            USP drug classification [BR:br08302]
             Immunological Agents
              Immunological Agents, Other
               JAK Inhibitors
                Upadacitinib
                 D11048  Upadacitinib hydrate (JAN)
            Therapeutic category of drugs in Japan [BR:br08301]
             3  Agents affecting metabolism
              39  Other agents affecting metabolism
               399  Miscellaneous
                3999  Others
                 D11048  Upadacitinib hydrate (JAN)
            Drug groups [BR:br08330]
             Anti-inflammatory
              DG01985  Disease modifying anti-rheumatic drug (DMARD)
               DG02020  JAK inhibitor
                DG02829  Upadacitinib
                 D11048  Upadacitinib hydrate
             Dermatological agent
              DG03243  Atopic dermatitis agent
               D11048  Upadacitinib hydrate
             Metabolizing enzyme substrate
              DG01644  CYP2D6 substrate
               DG02829  Upadacitinib
                D11048  Upadacitinib hydrate
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG02829  Upadacitinib
                 D11048  Upadacitinib hydrate
            Drug classes [BR:br08332]
             Immunological agent
              DG02020  JAK inhibitor
               D11048  Upadacitinib hydrate
             Antirheumatic agent
              DG01985  Disease modifying anti-rheumatic drug (DMARD)
               D11048  Upadacitinib hydrate
             Dermatological agent
              DG03243  Atopic dermatitis agent
               D11048  Upadacitinib hydrate
            Target-based classification of drugs [BR:br08310]
             Protein kinases
              Non-receptor tyrosine kinases
               JAK family
                JAK1
                 D11048  Upadacitinib hydrate (JAN) &lt;JP&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D11048
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D11048
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D11048
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D11048
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D11048
            Drug groups [BR:br08330]
             Anti-inflammatory
              DG01985  Disease modifying anti-rheumatic drug (DMARD)
               DG02020  JAK inhibitor
                DG02829  Upadacitinib
             Metabolizing enzyme substrate
              DG01644  CYP2D6 substrate
               DG02829  Upadacitinib
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG02829  Upadacitinib
DBLINKS     PubChem: 363669761
ATOM        55
            1   C8y C    17.0421  -19.4967
            2   C8x C    17.0421  -20.8292
            3   N5x N    18.2344  -21.5306
            4   C8y C    19.4266  -20.8292
            5   C8y C    19.4266  -19.4967
            6   N4y N    18.2344  -18.7954
            7   N4x N    20.7591  -21.3202
            8   C8x C    21.6007  -20.1279
            9   C8x C    20.7591  -19.0058
            10  C8y C    17.9538  -17.3928
            11  C8x C    16.5512  -17.2525
            12  N5x N    15.9901  -18.5149
            13  C1y C    18.8655  -16.3408
            14  C1y C    20.3383  -16.3408
            15  C1x C    20.6890  -14.9381
            16  N1y N    19.5669  -14.1667
            17  C1x C    18.4448  -15.0083
            18  C1b C    21.1799  -17.4629
            19  C1a C    22.5825  -17.2525
            20  C5a C    19.5669  -12.7640
            21  O5a O    20.7591  -12.0627
            22  N1b N    18.3045  -12.0627
            23  C1b C    17.1122  -12.7640
            24  C1d C    15.9200  -12.0627
            25  X   F    14.7277  -11.3614
            26  X   F    16.6213  -10.8705
            27  X   F    15.2187  -13.2550
            28  O0  O    27.9300  -20.3700
            29  C8y C    17.0421  -19.4967
            30  C8x C    17.0421  -20.8292
            31  N5x N    18.2344  -21.5306
            32  C8y C    19.4266  -20.8292
            33  C8y C    19.4266  -19.4967
            34  N4y N    18.2344  -18.7954
            35  C8y C    17.9538  -17.3928
            36  C8x C    16.5512  -17.2525
            37  N5x N    15.9901  -18.5149
            38  C1y C    18.8655  -16.3408
            39  C1y C    20.3383  -16.3408
            40  C1x C    20.6890  -14.9381
            41  N1y N    19.5669  -14.1667
            42  C1x C    18.4448  -15.0083
            43  C5a C    19.5669  -12.7640
            44  O5a O    20.7591  -12.0627
            45  N1b N    18.3045  -12.0627
            46  C1b C    17.1122  -12.7640
            47  C1d C    15.9200  -12.0627
            48  X   F    14.7277  -11.3614
            49  X   F    16.6213  -10.8705
            50  X   F    15.2187  -13.2550
            51  C1b C    21.1799  -17.4629
            52  C1a C    22.5825  -17.2525
            53  C8x C    20.7591  -19.0058
            54  C8x C    21.6007  -20.1279
            55  N4x N    20.7591  -21.3202
BOND        60
            1     1   2 1
            2     2   3 2
            3     3   4 1
            4     4   5 2
            5     5   6 1
            6     1   6 1
            7     4   7 1
            8     7   8 1
            9     8   9 2
            10    5   9 1
            11    6  10 1
            12   10  11 2
            13   11  12 1
            14    1  12 2
            15   13  10 1 #Up
            16   13  14 1
            17   14  15 1
            18   15  16 1
            19   16  17 1
            20   13  17 1
            21   14  18 1 #Up
            22   18  19 1
            23   16  20 1
            24   20  21 2
            25   20  22 1
            26   22  23 1
            27   23  24 1
            28   24  25 1
            29   24  26 1
            30   24  27 1
            31   29  30 1
            32   30  31 2
            33   31  32 1
            34   32  33 2
            35   33  34 1
            36   29  34 1
            37   32  55 1
            38   55  54 1
            39   54  53 2
            40   33  53 1
            41   34  35 1
            42   35  36 2
            43   36  37 1
            44   29  37 2
            45   38  35 1 #Up
            46   38  39 1
            47   39  40 1
            48   40  41 1
            49   41  42 1
            50   38  42 1
            51   39  51 1 #Up
            52   51  52 1
            53   41  43 1
            54   43  44 2
            55   43  45 1
            56   45  46 1
            57   46  47 1
            58   47  48 1
            59   47  49 1
            60   47  50 1
BRACKET     1    13.8600  -22.7500   13.8600  -10.1500
            1    24.4300  -10.1500   24.4300  -22.7500
            1  2
  ORIGINAL  1    1   2   3   4   5   6  10  11  12  13  14  15  16  17  20  21
            1   22  23  24  25  26  27  18  19   9   8   7
  REPEAT    1   29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44
            1   45  46  47  48  49  50  51  52  53  54  55
///
